# Top 10 intervention extracts from S3-Leitlinie_Lungenkarzinom_2025_IC_cleaned.json

=== Ranked Intervention 1 (Extract #3, Intervention) — Score: 8 ===
esearch or “first principles”
) Category - Does this intervention help? (Treatment Benefits): Systematic re-
view of randomized trials or n-of-1 trials
) Category - Does this intervention help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized controlled cohort/follow-up study (a systematic review is generally bet-
ter than an individual study)
) Category - Does this intervention help? (Treatment Benefits): Case-series,
case-control studies, or historically controlled studies (a systematic rev

=== Ranked Intervention 2 (Extract #32, Intervention) — Score: 8 ===
is intervention help? (Treatment Benefits): Systematic re-
Row 6: |view of randomized trials or n-of-1 trials
Row 7: |
Row 8: )|Category - Does this intervention help? (Treatment Benefits): Randomized
Row 9: |trial or observational study with dramatic effect
Row 10: |
Row 11: )|Category - Does this intervention help? (Treatment Benefits): Non-random-
Row 12: |ized controlled cohort/follow-up study (a systematic review is generally bet-
Row 13: |
Row 14: |ter than an individual study)
Row 15: )|Category - Does this intervention help? (Treatment Benefits): Case-series,
Row 16: |case-control studies, or hist

=== Ranked Intervention 3 (Extract #49, Treatment) — Score: 8 ===
inciples”
) Category - Does this intervention help? (Treatment Benefits): Systematic re-
view of randomized trials or n-of-1 trials
) Category - Does this intervention help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized controlled cohort/follow-up study (a systematic review is generally bet-
ter than an individual study)
) Category - Does this intervention help? (Treatment Benefits): Case-series,
case-control studies, or historically controlled studies (a systematic review is
generally

=== Ranked Intervention 4 (Extract #60, Treatment) — Score: 8 ===
cancer. Lung Cancer. 2002;36:1-6. URL:
687. Perng RP, Wu MF, Lin SY, Chen YM, Lin JY, Whang-Peng J. A phase I feasibility and pharmaco-
kinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anticancer
Drugs. 1997;8:565-573. URL:
688. Scott WJ, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest.
Clin Oncol Vol 20, 2603-4 and 2604-5). J Clin Oncol. 2002;20:247-253. URL:
(Comment to Marino, P, Cancer, Vol 76, p 593 - 601). Cancer. 1996;77:2413-2414. URL:
Cancer Institute of Canada and intergroup trial JBR10 and a review of the literature. Lung
C

=== Ranked Intervention 5 (Extract #1, Intervention) — Score: 7 ===
Oxf
5 (Oxf
ndlagen der
nzgrad
ford 2009)
ford 2011)
ford 2011)
ford 2011)
ford 2011)
ford 2011)
© L
Methodik 29
Beschreibung
) Therapy/Prevention, Aetiology, Harm: Expert opinion without explicit critical
appraisal, or based on physiology, bench research or “first principles”
) Category - Does this intervention help? (Treatment Benefits): Systematic re-
view of randomized trials or n-of-1 trials
) Category - Does this intervention help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized control

=== Ranked Intervention 6 (Extract #2, Intervention) — Score: 7 ===
ng
) Therapy/Prevention, Aetiology, Harm: Expert opinion without explicit critical
appraisal, or based on physiology, bench research or “first principles”
) Category - Does this intervention help? (Treatment Benefits): Systematic re-
view of randomized trials or n-of-1 trials
) Category - Does this intervention help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized controlled cohort/follow-up study (a systematic review is generally bet-
ter than an individual study)
) Category - Does this int

=== Ranked Intervention 7 (Extract #4, Intervention) — Score: 7 ===
ion help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized controlled cohort/follow-up study (a systematic review is generally bet-
ter than an individual study)
) Category - Does this intervention help? (Treatment Benefits): Case-series,
case-control studies, or historically controlled studies (a systematic review is
generally better than an individual study)
) Category - Does this intervention help? (Treatment Benefits): Mechanism-
based reasoning
Hohe Qualität der Evidenz nach GRADE = Wir

=== Ranked Intervention 8 (Extract #47, Treatment) — Score: 7 ===
er
nzgrad
ford 2009)
ford 2011)
ford 2011)
ford 2011)
ford 2011)
ford 2011)
© L
Methodik 29
Beschreibung
) Therapy/Prevention, Aetiology, Harm: Expert opinion without explicit critical
appraisal, or based on physiology, bench research or “first principles”
) Category - Does this intervention help? (Treatment Benefits): Systematic re-
view of randomized trials or n-of-1 trials
) Category - Does this intervention help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized controlled cohort/follow

=== Ranked Intervention 9 (Extract #48, Treatment) — Score: 7 ===
ion, Aetiology, Harm: Expert opinion without explicit critical
appraisal, or based on physiology, bench research or “first principles”
) Category - Does this intervention help? (Treatment Benefits): Systematic re-
view of randomized trials or n-of-1 trials
) Category - Does this intervention help? (Treatment Benefits): Randomized
trial or observational study with dramatic effect
) Category - Does this intervention help? (Treatment Benefits): Non-random-
ized controlled cohort/follow-up study (a systematic review is generally bet-
ter than an individual study)
) Category - Does this intervention help? (

=== Ranked Intervention 10 (Extract #56, Treatment) — Score: 7 ===
suchungen war eine cisplatinhaltige The-
rapie einer platinfreien Strategie überlegen Wolf et al. 1987 [1399], Havemann et al.
1987 [1368]. Eine Wirksamkeitsverstärkung durch Zugabe von Etoposid wurde auch
in einer Studie von Jackson et al 1984 [1400] gesehen. In der Studie der North Central
Cancer Treatment Group (NCCTG) [1401] führte die Addition von Etoposid zum ACO-
Schema bei LD-Patienten zur Verbesserung der Prognose. Dieses ACO-E-Schema
wurde in einer SWOG-Studie [1402] gegen das Alternieren von ACO und PE getestet,
wobei sich eine geringe Verlängerung der medianen Überlebenszeit (16.5 vs 15.1
M

